Litcius/Paper detail

Cross-Reactive Anti-Nucleocapsid Protein Immunity against Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus in Multiple Species

Merve Kalkan-Yazıcı, Elif Karaaslan, Nesibe Selma Çetin, Sevde Hasanoğlu, Filiz Güney, Ümit Zeybek, Mehmet Ziya Doymaz

2021Journal of Virology26 citationsDOIOpen Access PDF

Abstract

family, are transmitted to mammals by tick bites. CCHFV is considered to be a severe threat to public health and causes hemorrhagic diseases with a high mortality rate, and there are neither preventative nor therapeutic medications against CCHFV disease. HAZV, on the other hand, is not a pathogen to humans and can be studied under BSL-2 conditions. The antigenic relationship between these viruses is of interest for vaccines and for preventative investigations. Here, we demonstrate cross-reactivity in anti-NP humoral immune response between NPs of HAZV and CCHFV in multiple species. These results underline the utility of HAZV as a surrogate model to study CCHFV infection.

Topics & Concepts

BiologyCrimean–Congo hemorrhagic feverVirologyVirusImmunityTickBunyaviridaeImmunologyImmune systemViral Infections and VectorsViral Infections and Outbreaks ResearchVector-Borne Animal Diseases
Cross-Reactive Anti-Nucleocapsid Protein Immunity against Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus in Multiple Species | Litcius